CIBC Bancorp USA’s Cogent Biosciences COGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$528K Buy
16,487
+7,279
+79% +$269K ﹤0.01% 1342
2026
Q2
$356K Buy
9,208
+2,009
+28% +$70.3K ﹤0.01% 1453
2026
Q1
$277K Buy
+7,199
New +$266K ﹤0.01% 1459
2025
Q3
$199K Buy
+13,857
New +$164K ﹤0.01% 1264

Other funds holding COGT

CIBC Bancorp USA's COGT Position: Q3 2026 in Review

CIBC Bancorp USA increased its Cogent Biosciences (COGT) stake by 79% in Q3 2026, buying an estimated $269K and bringing the position to 16,487 shares worth $528K. The position accounts for ﹤0.01% of the portfolio, ranked #1342.

CIBC Bancorp USA first reported a position in COGT in Q3 2025 and has held it in 4 quarters since. 314 funds tracked by Wall St. Rank hold COGT as of Q3 2026.

  • CIBC Bancorp USA held 16,487 shares of Cogent Biosciences worth $528K as of Q3 2026.
  • CIBC Bancorp USA bought 7,279 Cogent Biosciences shares in Q3 2026, an estimated $269K.
  • Cogent Biosciences made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2026, its #1342 holding.
  • CIBC Bancorp USA first reported a position in Cogent Biosciences in Q3 2025 and has held it in 4 quarters since.
  • 314 funds tracked by Wall St. Rank held Cogent Biosciences as of Q3 2026.

Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.